Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 07:16 PM EDT

Sutro Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-208.7M -245.22M -227.46M -123.95M -124.45M -114.96M -106.79M -172.45M -142.66M -130.14M -119.2M -122.73M -134.15M -114.29M -105.54M -126.96M -78.92M -42.89M
Depreciation & Amortization
7.47M 7.36M 7.22M 7.08M 7.02M 6.96M 6.82M 6.61M 6.31M 5.98M 5.69M 5.48M 5.16M 4.88M 4.84M 4.7M 4.55M 4.49M
Stock-Based Compensation
23.26M 24.16M 24.69M 25M 24.45M 24.95M 24.91M 24.54M 25.32M 25.35M 26.3M 27.34M 27.05M 26.26M 23.24M 19.44M 16.06M 13.16M
Other Working Capital
-79.81M -2.09M -19.27M -7.56M 8.69M -17.89M -20.25M 2.31M -11.98M 83.29M 100.29M 84.39M 89.23M -6.4M -12.61M -12.46M -20.65M -21.51M
Other Non-Cash Items
11.69M 2.65M -4.88M 8.17M 32.51M 32.58M 36.16M -1.77M -12.01M -8.59M -13.65M 4.41M 11.3M 6.91M 6.16M 1.2M -1.41M 653K
Deferred Income Tax
n/a n/a n/a -25.08M -28.17M -38.33M -38.33M -13.25M -10.16M n/a n/a 3.37M -323K -3.95M 7.24M 41.2M 15.36M -29.79M
Change in Working Capital
-82.58M 16.37M 8.9M 3.05M 13.92M -26.58M -34.38M 6.77M 83.01M 85.22M 104.41M 87.97M 6.54M -6.32M -17.62M -18.57M -27.9M -25.12M
Operating Cash Flow
-248.86M -194.68M -191.54M -105.73M -74.72M -115.37M -111.62M -149.55M -50.2M -22.19M 3.55M 5.83M -84.43M -86.5M -81.68M -78.98M -72.26M -79.5M
Capital Expenditures
-3.16M -3.83M -3.1M -3.47M -2.97M -3.82M -4.32M -6.24M -6.65M -7.25M -7.86M -7.03M -11.29M -14.5M -15.32M -14.41M -12.39M -8.74M
Cash Acquisitions
n/a n/a n/a 22.07M 135.76M 68M -391K 6.28M -30.12M -12.47M 55.92M 42.88M -34.42M 15.69M 15.69M n/a n/a n/a
Purchase of Investments
-340.16M -468.9M -461.52M -416.06M -611.27M -542.54M -460.3M -481.9M -343.09M -258.44M -216.67M -137.12M -61.35M -95.12M -248.73M -242.85M -241.79M -291.75M
Sales Maturities Of Investments
490.37M 536.82M 609.08M 452.99M 460.44M 539.09M 460.69M 469.84M 367.43M 265.13M 189.5M 167.78M 172.06M 167M 166.73M 154.88M 154.34M 137.63M
Other Investing Acitivies
74.05M 74.05M 74.05M 51.98M -135.76M -68M 391K -6.27M 30.13M 12.48M -21.38M -8.33M 71.72M 32.9M -120.99M -105.22M -104.7M -171.36M
Investing Cash Flow
221.1M 138.15M 218.51M 107.51M -153.8M -7.27M -3.92M -18.29M 17.69M -553K -35.02M 23.64M 99.44M 57.4M -97.31M -102.29M -99.75M -162.76M
Debt Repayment
4.08M 4.08M n/a -7.21M -10.33M -13.46M -12.5M -12.5M -12.5M -9.38M -6.25M -3.13M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-24K -61K -435K 79K 79K 116K 490K n/a n/a n/a -404K -411K -991K -991K -994K -987K -407K -407K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
92.11M 92.13M 91.94M -485K -3.98M 135.79M 137.13M 137.13M 141.34M 7.1M 6.9M 7.41M 7.73M 2.2M 3.26M 4.44M 3.35M 94.81M
Financial Cash Flow
999K 97.55M 94.05M 90.95M 84.2M 125.37M 137.55M 152.9M 188.49M 56.31M 48.31M 36.6M 7.71M 2.19M 3.26M 147.6M 163.91M 255.37M
Net Cash Flow
-26.76M 41.01M 121.04M 92.75M -144.31M 2.75M 22.01M -14.95M 155.98M 33.57M 16.84M 66.07M 22.72M -26.92M -175.74M -33.66M -8.1M 13.11M
Free Cash Flow
-252.02M -198.51M -194.64M -109.2M -77.69M -119.19M -115.93M -155.79M -56.85M -29.43M -4.31M -1.2M -95.71M -101M -97M -93.39M -84.65M -88.24M